"Accordingly, a demonstration of equivalence in
anti-Xa activity, anti-lla activity, and anti-Xa/anti-lla ratio between the generic drug product's
enoxaparin and Lovenox's enoxaparin provides important evidence of equivalence ofbiochemical
characteristics - which, at a minimum, is responsible for an important and well-established
mechanism of action that explains, in significant part, the pharmacological activity for LMWHs
(including enoxaparin)."
So what are corresponding markers in Copaxone ? its hard to understand from the peptimmune's cp
Market Data 
Markets 
AI
